Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials

Pirfenidone is an antifibrotic agent that has been evaluated in three multinational phase 3 trials in patients with idiopathic pulmonary fibrosis (IPF). We analysed pooled data from the multinational trials to obtain the most precise estimates of the magnitude of treatment effect on measures of dise...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Eur Respir J
Main Authors: Noble, Paul W., Albera, Carlo, Bradford, Williamson Z., Costabel, Ulrich, du Bois, Roland M., Fagan, Elizabeth A., Fishman, Robert S., Glaspole, Ian, Glassberg, Marilyn K., Lancaster, Lisa, Lederer, David J., Leff, Jonathan A., Nathan, Steven D., Pereira, Carlos A., Swigris, Jeffrey J., Valeyre, Dominique, King, Talmadge E.
Formato: Artigo
Idioma:Inglês
Publicado: European Respiratory Society 2016
Assuntos:
Original Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4697914/
https://ncbi.nlm.nih.gov/pubmed/26647432
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/13993003.00026-2015
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares